1887

Abstract

Investigations of the bacterial family have enabled the development of secondary metabolites critical to human health. Historical investigation of bacterial families for natural product discovery has focused on terrestrial strains, where time-consuming isolation processes often lead to the rediscovery of known compounds. To investigate the secondary metabolite potential of marine-derived , 38 strains were sequenced, assembled and analysed using antiSMASH and BiG-SLiCE. BiG-SLiCE contains a near-comprehensive dataset of approximately 1.2 million publicly available biosynthetic gene clusters from primarily terrestrial strains. Our marine-derived were directly compared to BiG-SLiCE’s preprocessed database using BiG-SLiCE’s query mode; genetic diversity within our strains was uncovered using BiG-SCAPE and metric multidimensional scaling analysis. Our analysis of marine-derived emphasizes the clear need for broader genomic investigations of marine strains to fully realize their potential as sources of new natural products.

Funding
This study was supported by the:
  • National Institutes of Health (US) (Award T32GM008349)
    • Principle Award Recipient: ImraanAlas
  • National Institutes of Health (US) (Award R01AT009874)
    • Principle Award Recipient: TimS. Bugni
  • National Institutes of Health (US) (Award U19AI142720)
    • Principle Award Recipient: TimS. Bugni
  • National Institutes of Health (US) (Award U19AI109673)
    • Principle Award Recipient: TimS. Bugni
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/mgen/10.1099/mgen.0.001167
2024-01-04
2024-12-03
Loading full text...

Full text loading...

/deliver/fulltext/mgen/10/1/mgen001167.html?itemId=/content/journal/mgen/10.1099/mgen.0.001167&mimeType=html&fmt=ahah

References

  1. Aminov RI. A brief history of the antibiotic era: lessons learned and challenges for the future. Front Microbiol 2010; 1:134 [View Article] [PubMed]
    [Google Scholar]
  2. Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev 2017; 117:12415–12474 [View Article] [PubMed]
    [Google Scholar]
  3. Segala FV, Bavaro DF, Di Gennaro F, Salvati F, Marotta C et al. Impact of SARS-CoV-2 epidemic on antimicrobial resistance: a literature review. Viruses 2021; 13:2110 [View Article] [PubMed]
    [Google Scholar]
  4. COVID-19: U.S Impact on Antimicrobial Resistance, Special Report 2022. National Center for Emerging and Zoonotic Infectious Diseases; 2022 https://stacks.cdc.gov/view/cdc/117915 accessed 10 July 2023
  5. Patridge E, Gareiss P, Kinch MS, Hoyer D. An analysis of FDA-approved drugs: natural products and their derivatives. Drug Discov Today 2016; 21:204–207 [View Article] [PubMed]
    [Google Scholar]
  6. Stratton CF, Newman DJ, Tan DS. Cheminformatic comparison of approved drugs from natural product versus synthetic origins. Bioorg Med Chem Lett 2015; 25:4802–4807 [View Article] [PubMed]
    [Google Scholar]
  7. Qi S, Gui M, Li H, Yu C, Li H et al. Secondary metabolites from marine Micromonospora: chemistry and bioactivities. Chem Biodivers 2020; 17:e2000024 [View Article] [PubMed]
    [Google Scholar]
  8. Manivasagan P, Venkatesan J, Sivakumar K, Kim S-K. Pharmaceutically active secondary metabolites of marine actinobacteria. Microbiol Res 2014; 169:262–278 [View Article] [PubMed]
    [Google Scholar]
  9. Ellis GA, Thomas CS, Chanana S, Adnani N, Szachowicz E et al. Brackish habitat dictates cultivable Actinobacterial diversity from marine sponges. PLoS One 2017; 12:e0176968 [View Article] [PubMed]
    [Google Scholar]
  10. Jensen PR, Gontang E, Mafnas C, Mincer TJ, Fenical W. Culturable marine actinomycete diversity from tropical Pacific Ocean sediments. Environ Microbiol 2005; 7:1039–1048 [View Article] [PubMed]
    [Google Scholar]
  11. Selim MSM, Abdelhamid SA, Mohamed SS. Secondary metabolites and biodiversity of actinomycetes. J Genet Eng Biotechnol 2021; 19:72 [View Article] [PubMed]
    [Google Scholar]
  12. Subramani R, Sipkema D. Marine rare actinomycetes: a promising source of structurally diverse and unique novel natural products. Mar Drugs 2019; 17:249 [View Article] [PubMed]
    [Google Scholar]
  13. Jensen PR, Moore BS, Fenical W. The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery. Nat Prod Rep 2015; 32:738–751 [View Article] [PubMed]
    [Google Scholar]
  14. Kim H, Kim S, Kim M, Lee C, Yang I et al. Bioactive natural products from the genus Salinospora: a review. Arch Pharm Res 2020; 43:1230–1258 [View Article] [PubMed]
    [Google Scholar]
  15. Ziemert N, Lechner A, Wietz M, Millán-Aguiñaga N, Chavarria KL et al. Diversity and evolution of secondary metabolism in the marine actinomycete genus Salinispora. Proc Natl Acad Sci U S A 2014; 111:E1130–E1139 [View Article] [PubMed]
    [Google Scholar]
  16. Letzel A-C, Li J, Amos GCA, Millán-Aguiñaga N, Ginigini J et al. Genomic insights into specialized metabolism in the marine actinomycete Salinispora. Environ Microbiol 2017; 19:3660–3673 [View Article] [PubMed]
    [Google Scholar]
  17. Janssen PH. Identifying the dominant soil bacterial taxa in libraries of 16S rRNA and 16S rRNA genes. Appl Environ Microbiol 2006; 72:1719–1728 [View Article] [PubMed]
    [Google Scholar]
  18. Yan S, Zeng M, Wang H, Zhang H. Micromonospora: a prolific source of bioactive secondary metabolites with therapeutic potential. J Med Chem 2022; 65:8735–8771 [View Article] [PubMed]
    [Google Scholar]
  19. Weinstein MJ, Luedemann GM, Oden EM, Wagman GH, Rosselet JP et al. Gentamicin,1 a new antibiotic complex from Micromonospora. J Med Chem 1963; 6:463–464 [View Article] [PubMed]
    [Google Scholar]
  20. Organization WH. World Health Organization model list of essential medicines: 21st list 2019; 2019 https://iris.who.int/handle/10665/325771 accessed 24 October 2023
  21. Waksman SA, Geiger WB, Bugie E. Micromonosporin, an antibiotic substance from a little-known group of microorganisms. J Bacteriol 1947; 53:355–357 [View Article] [PubMed]
    [Google Scholar]
  22. Hifnawy MS, Fouda MM, Sayed AM, Mohammed R, Hassan HM et al. The genus Micromonospora as a model microorganism for bioactive natural product discovery. RSC Adv 2020; 10:20939–20959 [View Article] [PubMed]
    [Google Scholar]
  23. Dulin CC, Sharma P, Frigo L, Voehler MW, Iverson TM et al. EvdS6 is a bifunctional decarboxylase from the everninomicin gene cluster. J Biol Chem 2023; 299:104893 [View Article] [PubMed]
    [Google Scholar]
  24. Zhang F, Zhao M, Braun DR, Ericksen SS, Piotrowski JS et al. A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science 2020; 370:974–978 [View Article] [PubMed]
    [Google Scholar]
  25. Zhao M, Zhang F, Zarnowski R, Barns K, Jones R et al. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle-mediated trafficking. J Clin Invest 2021; 131:e145123 [View Article] [PubMed]
    [Google Scholar]
  26. Wang Z, Wen Z, Liu L, Zhu X, Shen B et al. Yangpumicins F and G, enediyne congeners from Micromonospora yangpuensis DSM 45577. J Nat Prod 2019; 82:2483–2488 [View Article] [PubMed]
    [Google Scholar]
  27. Yan X, Chen J-J, Adhikari A, Yang D, Crnovcic I et al. Genome mining of Micromonospora yangpuensis DSM 45577 as a producer of an anthraquinone-fused enediyne. Org Lett 2017; 19:6192–6195 [View Article] [PubMed]
    [Google Scholar]
  28. Braesel J, Crnkovic CM, Kunstman KJ, Green SJ, Maienschein-Cline M et al. Complete genome of Micromonospora sp. strain B006 reveals biosynthetic potential of a lake michigan actinomycete. J Nat Prod 2018; 81:2057–2068 [View Article] [PubMed]
    [Google Scholar]
  29. Parks DH, Chuvochina M, Rinke C, Mussig AJ, Chaumeil P-A et al. GTDB: an ongoing census of bacterial and archaeal diversity through a phylogenetically consistent, rank normalized and complete genome-based taxonomy. Nucleic Acids Res 2022; 50:D785–D794 [View Article] [PubMed]
    [Google Scholar]
  30. Chaumeil P-A, Mussig AJ, Hugenholtz P, Parks DH. GTDB-Tk v2: memory friendly classification with the genome taxonomy database. Bioinformatics 2022; 38:5315–5316 [View Article] [PubMed]
    [Google Scholar]
  31. Hoskisson PA, Seipke RF. Cryptic or silent? The known unknowns, unknown knowns, and unknown unknowns of secondary metabolism. mBio 2020; 11:e02642-20 [View Article] [PubMed]
    [Google Scholar]
  32. Terlouw BR, Blin K, Navarro-Muñoz JC, Avalon NE, Chevrette MG et al. MIBiG 3.0: a community-driven effort to annotate experimentally validated biosynthetic gene clusters. Nucleic Acids Res 2023; 51:D603–D610 [View Article] [PubMed]
    [Google Scholar]
  33. Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res 2023; 51:W46–W50 [View Article] [PubMed]
    [Google Scholar]
  34. Navarro-Muñoz JC, Selem-Mojica N, Mullowney MW, Kautsar SA, Tryon JH et al. A computational framework to explore large-scale biosynthetic diversity. Nat Chem Biol 2020; 16:60–68 [View Article] [PubMed]
    [Google Scholar]
  35. Kautsar SA, van der Hooft JJJ, de Ridder D, Medema MH. BiG-SLiCE: a highly scalable tool maps the diversity of 1.2 million biosynthetic gene clusters. Gigascience 2021; 10:giaa154 [View Article] [PubMed]
    [Google Scholar]
  36. Saati-Santamaría Z, Selem-Mojica N, Peral-Aranega E, Rivas R, García-Fraile P. Unveiling the genomic potential of Pseudomonas type strains for discovering new natural products. Microb Genom 2022; 8:000758 [View Article] [PubMed]
    [Google Scholar]
  37. Wyche TP, Hou Y, Braun D, Cohen HC, Xiong MP et al. First natural analogs of the cytotoxic thiodepsipeptide thiocoraline A from a marine Verrucosispora sp. J Org Chem 2011; 76:6542–6547 [View Article] [PubMed]
    [Google Scholar]
  38. Adnani N, Chevrette MG, Adibhatla SN, Zhang F, Yu Q et al. Coculture of marine invertebrate-associated bacteria and interdisciplinary technologies enable biosynthesis and discovery of a new antibiotic, Keyicin. ACS Chem Biol 2017; 12:3093–3102 [View Article] [PubMed]
    [Google Scholar]
  39. Koren S, Walenz BP, Berlin K, Miller JR, Bergman NH et al. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res 2017; 27:722–736 [View Article] [PubMed]
    [Google Scholar]
  40. BUSCO Update: Novel and Streamlined Workflows along with Broader and Deeper Phylogenetic Coverage for Scoring of Eukaryotic, Prokaryotic, and Viral Genomes. Molecular Biology and Evolution, Oxford Academic; n.d https://academic.oup.com/mbe/article/38/10/4647/6329644 accessed 24 October 2022
  41. Mikheenko A, Prjibelski A, Saveliev V, Antipov D, Gurevich A. Versatile genome assembly evaluation with QUAST-LG. Bioinformatics 2018; 34:i142–i150 [View Article] [PubMed]
    [Google Scholar]
  42. Blin K, Shaw S, Steinke K, Villebro R, Ziemert N et al. antiSMASH 5.0: updates to the secondary metabolite genome mining pipeline. Nucleic Acids Res 2019; 47:W81–W87 [View Article] [PubMed]
    [Google Scholar]
  43. Blin K, Shaw S, Kloosterman AM, Charlop-Powers Z, van Wezel GP et al. antiSMASH 6.0: improving cluster detection and comparison capabilities. Nucleic Acids Res 2021; 49:W29–W35 [View Article] [PubMed]
    [Google Scholar]
  44. Alanjary M, Kronmiller B, Adamek M, Blin K, Weber T et al. The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery. Nucleic Acids Res 2017; 45:W42–W48 [View Article] [PubMed]
    [Google Scholar]
  45. Mungan MD, Alanjary M, Blin K, Weber T, Medema MH et al. ARTS 2.0: feature updates and expansion of the antibiotic resistant target seeker for comparative genome mining. Nucleic Acids Res 2020; 48:W546–W552 [View Article] [PubMed]
    [Google Scholar]
  46. Waskom ML. seaborn: statistical data visualization. JOSS 2021; 6:3021 [View Article]
    [Google Scholar]
  47. Van Rossum G, Drake FL. Python 3 Reference Manual Scotts Valley, CA: CreateSpace; 2009
    [Google Scholar]
  48. Emms DM, Kelly S. OrthoFinder: phylogenetic orthology inference for comparative genomics. Genome Biol 2019; 20:238 [View Article] [PubMed]
    [Google Scholar]
  49. Edgar RC. MUSCLE V5 enables improved estimates of phylogenetic tree confidence by ensemble bootstrapping. bioRxiv 20212021
    [Google Scholar]
  50. Capella-Gutiérrez S, Silla-Martínez JM, Gabaldón T. trimAl: a tool for automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics 2009; 25:1972–1973 [View Article] [PubMed]
    [Google Scholar]
  51. Minh BQ, Schmidt HA, Chernomor O, Schrempf D, Woodhams MD et al. IQ-TREE 2: new models and efficient methods for phylogenetic inference in the genomic era. Mol Biol Evol 2020; 37:1530–1534 [View Article] [PubMed]
    [Google Scholar]
  52. Kalyaanamoorthy S, Minh BQ, Wong TKF, von Haeseler A, Jermiin LS. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods 2017; 14:587–589 [View Article] [PubMed]
    [Google Scholar]
  53. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article] [PubMed]
    [Google Scholar]
  54. Parks DH, Chuvochina M, Waite DW, Rinke C, Skarshewski A et al. A standardized bacterial taxonomy based on genome phylogeny substantially revises the tree of life. Nat Biotechnol 2018; 36:996–1004 [View Article] [PubMed]
    [Google Scholar]
  55. Jain C, Rodriguez-R LM, Phillippy AM, Konstantinidis KT, Aluru S. High throughput ANI analysis of 90K prokaryotic genomes reveals clear species boundaries. Nat Commun 2018; 9:5114 [View Article] [PubMed]
    [Google Scholar]
  56. Kautsar SA, Blin K, Shaw S, Navarro-Muñoz JC, Terlouw BR et al. MIBiG 2.0: a repository for biosynthetic gene clusters of known function. Nucleic Acids Res 2020; 48:D454–D458 [View Article] [PubMed]
    [Google Scholar]
  57. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003; 13:2498–2504 [View Article] [PubMed]
    [Google Scholar]
  58. Cantrell CD. Modern Mathematical Methods for Physicists and Engineers Cambridge University Press; 2000 [View Article]
    [Google Scholar]
  59. Guimarães AC, Meireles LM, Lemos MF, Guimarães MCC, Endringer DC et al. Antibacterial activity of terpenes and terpenoids present in essential oils. Molecules 2019; 24:2471 [View Article] [PubMed]
    [Google Scholar]
  60. Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-cancer potential of Cannabinoids, Terpenes, and Flavonoids present in Cannabis. Cancers 2020; 12:1985 [View Article] [PubMed]
    [Google Scholar]
  61. Rao A, Zhang Y, Muend S, Rao R. Mechanism of antifungal activity of terpenoid phenols resembles calcium stress and inhibition of the TOR pathway. Antimicrob Agents Chemother 2010; 54:5062–5069 [View Article] [PubMed]
    [Google Scholar]
  62. Scherlach K, Hertweck C. Mining and unearthing hidden biosynthetic potential. Nat Commun 2021; 12:3864 [View Article] [PubMed]
    [Google Scholar]
  63. Hudson GA, Mitchell DA. RiPP antibiotics: biosynthesis and engineering potential. Curr Opin Microbiol 2018; 45:61–69 [View Article] [PubMed]
    [Google Scholar]
  64. Hetrick KJ, van der Donk WA. Ribosomally synthesized and post-translationally modified peptide natural product discovery in the genomic era. Curr Opin Chem Biol 2017; 38:36–44 [View Article] [PubMed]
    [Google Scholar]
  65. Mohr KI, Volz C, Jansen R, Wray V, Hoffmann J et al. Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed Engl 2015; 54:11254–11258 [View Article] [PubMed]
    [Google Scholar]
  66. Russell AH, Truman AW. Genome mining strategies for ribosomally synthesised and post-translationally modified peptides. Comput Struct Biotechnol J 2020; 18:1838–1851 [View Article] [PubMed]
    [Google Scholar]
  67. Frattaruolo L, Lacret R, Cappello AR, Truman AW. A genomics-based approach identifies a thioviridamide-like compound with selective anticancer activity. ACS Chem Biol 2017; 12:2815–2822 [View Article] [PubMed]
    [Google Scholar]
  68. Center for High Throughput Computing; 2006 https://chtc.cs.wisc.edu/
/content/journal/mgen/10.1099/mgen.0.001167
Loading
/content/journal/mgen/10.1099/mgen.0.001167
Loading

Data & Media loading...

Supplements

Loading data from figshare Loading data from figshare
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error